(Q40447654)

20 September 2017

title

Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial. (English)

1 reference

Markus Benedikt Skrifvars

20 September 2017

main subject

traumatic brain injury

0 references

1 reference

14

Markus Skrifvars

0 references

Olivier Huet

Olivier Huet

10

0 references

Alistair Nichol

Alistair Nichol

1

0 references

Alistair Nichol

Alistair Nichol

1

0 references

Michael Bailey

Michael Bailey

7

0 references

Rinaldo Bellomo

Rinaldo Bellomo

18

0 references

Jacques Duranteau

9

Jacques Duranteau

1 reference

20 September 2017

6

Yaseen Arabi

1 reference

20 September 2017

5

Jeffrey Presneill

1 reference

20 September 2017

3

Lorraine Little

1 reference

20 September 2017

4

Samir Haddad

1 reference

20 September 2017

13

Ville Pettilä

1 reference

20 September 2017

15

Shirley Vallance

1 reference

20 September 2017

16

Dinesh Varma

1 reference

20 September 2017

EPO-TBI Investigators

19

EPO-TBI Investigators

1 reference

ANZICS Clinical Trials Group

20 September 2017

20

ANZICS Clinical Trials Group

1 reference

20 September 2017

Craig French

2

1 reference

20 September 2017

D James Cooper

8

1 reference

20 September 2017

Anne Mak

11

1 reference

20 September 2017

Colin McArthur

12

1 reference

20 September 2017

Markus Skrifvars

14

1 reference

20 September 2017

Judy Wills

17

1 reference

20 September 2017

language of work or name

English

0 references

publication date

6 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

volume

386

1 reference

20 September 2017

issue

10012

1 reference

20 September 2017

page(s)

2499-2506

1 reference

Epidemiology and 12-month outcomes from traumatic brain injury in australia and new zealand

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Clinical trials in traumatic brain injury: past experience and current developments.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Saline or albumin for fluid resuscitation in patients with traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Prehospital rapid sequence intubation improves functional outcome for patients with severe traumatic brain injury: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

The role of erythropoietin in central and peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Science review: recombinant human erythropoietin in critical illness: a role beyond anemia?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Pathophysiology of cerebral ischemia and brain trauma: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Efficacy and safety of epoetin alfa in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin for traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin in traumatic brain injury: study protocol for a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Correction of anemia with epoetin alfa in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin use in critically ill patients: forest and trees

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Indication creep: physician beware

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

A clinical trial of progesterone for severe traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Very early administration of progesterone for acute traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

Erythropoietin for critically ill trauma patients: A missed opportunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2900386-4

7 January 2021

10.1016/S0140-6736(15)00386-4

Identifiers

DOI

1 reference

20 September 2017

1 reference